Direct costs of asthma in Brazil: a comparison between controlled and uncontrolled asthmatic patients



Título del documento: Direct costs of asthma in Brazil: a comparison between controlled and uncontrolled asthmatic patients
Revue: Brazilian journal of medical and biological research
Base de datos: PERIÓDICA
Número de sistema: 000350917
ISSN: 0100-879X
Autores: 1
1
1
1
1
Instituciones: 1Universidade Federal de Sao Paulo, Escola Paulista de Medicina, Sao Paulo. Brasil
Año:
Periodo: Jul
Volumen: 40
Número: 7
Paginación: 943-948
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Experimental, aplicado
Resumen en inglés Asthma is a common chronic illness that imposes a heavy burden on all aspects of the patient's life, including personal and health care cost expenditures. To analyze the direct cost associated to uncontrolled asthma patients, a cross-sectional study was conducted to determine costs related to patients with uncontrolled and controlled asthma. Uncontrolled patient was defined by daytime symptoms more than twice a week or nocturnal symptoms during two consecutive nights or any limitations of activities, or need for relief rescue medication more than twice a week, and an ACQ score less than 2 points. A questionnaire about direct cost stratification in health services, including emergency room visits, hospitalization, ambulatory visits, and asthma medications prescribed, was applied. Ninety asthma patients were enrolled (45 uncontrolled/45 controlled). Uncontrolled asthmatics accounted for higher health care expenditures than controlled patients, US$125.45 and US$15.58, respectively [emergency room visits (US$39.15 vs US$2.70) and hospitalization (US$86.30 vs US$12.88)], per patient over 6 months. The costs with medications in the last month for patients with mild, moderate and severe asthma were US$1.60, 9.60, and 25.00 in the uncontrolled patients, respectively, and US$6.50, 19.00 and 49.00 in the controlled patients. In view of the small proportion of uncontrolled subjects receiving regular maintenance medication (22.2%) and their lack of resources, providing free medication for uncontrolled patients might be a cost-effective strategy for the public health system
Disciplinas: Medicina
Palabras clave: Neumología,
Salud pública,
Asma,
Atención a la salud,
Costo de tratamiento,
Servicios de salud
Keyword: Medicine,
Pneumology,
Public health,
Asthma,
Health care,
Treatment cost,
Health services
Texte intégral: Texto completo (Ver HTML)